Advances in relationship between pyroptosis and pulmonary arterial hypertension and therapeutic drugs / 中国药理学通报
Qian YAN; Yang SUN; Jun-Peng LONG; Jiao YAO; Yu-Ting LIN; Song-Wei YANG; Yan-Tao YANG; Gang PEI; Qi-Di AI; Nai-Hong CHEN; Qian YAN; Yang SUN; Jun-Peng LONG; Jiao YAO; Yu-Ting LIN; Song-Wei YANG; Yan-Tao YANG; Gang PEI; Qi-Di AI; Nai-Hong CHEN; Sha-Sha LIU; Nai-Hong CHEN.
Chinese Pharmacological Bulletin
; (12): 25-30, 2024.
Artículo
en Zh
| WPRIM | ID: wpr-1013606
Pyroptosis is the programmed death of cells accompanied by an inflammatory response and is widely involved in the development of a variety of diseases, such as infectious diseases, cardiovascular diseases, and neurodegeneration. It has been shown that cellular scorching is involved in the pathogenesis of pulmonary arterial hypertension ( PAH) in cardiovascular diseases. Patients with PAH have perivascular inflammatory infiltrates in lungs, pulmonary vasculopathy exists in an extremely inflam-matory microenvironment, and pro-inflammatory factors in cellular scorching drive pulmonary vascular remodelling in PAH patients. This article reviews the role of cellular scorch in the pathogenesis of PAH and the related research on drugs for the treatment of PAH, with the aim of providing new ideas for clinical treatment of PAH.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados